These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7745014)

  • 1. Pharmacokinetics of human follicle-stimulating hormone in gonadotropin-deficient men.
    Handelsman DJ; Turner L; Boylan LM; Conway AJ
    J Clin Endocrinol Metab; 1995 May; 80(5):1657-63. PubMed ID: 7745014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of recombinant human follicle stimulating hormone after intravenous, intramuscular, and subcutaneous administration in monkeys, and comparison with intravenous administration of urinary follicle stimulating hormone.
    Porchet HC; Le Cotonnec JY; Canali S; Zanolo G
    Drug Metab Dispos; 1993; 21(1):144-50. PubMed ID: 8095209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and Pharmacodynamics of Follicle-Stimulating Hormone in Healthy Women Receiving Single and Multiple Doses of Highly Purified Human Menotrophin and Urofollitrophin.
    Di Stefano AF; Rusca A; Radicioni MM; Loprete L; Binelli D; Caccia G; Cometti B
    Clin Drug Investig; 2016 Dec; 36(12):1031-1044. PubMed ID: 27638053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady state pharmacokinetics.
    le Contonnec JY; Porchet HC; Beltrami V; Khan A; Toon S; Rowland M
    Fertil Steril; 1994 Apr; 61(4):679-86. PubMed ID: 8150110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man.
    Matsumoto AM; Karpas AE; Bremner WJ
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1184-92. PubMed ID: 3084535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous administration of gonadotropin-releasing hormone: absorption kinetics and gonadotropin responses.
    Hurley DM; Clarke IJ; Shelton R; Burger HG
    J Clin Endocrinol Metab; 1987 Jul; 65(1):46-52. PubMed ID: 3108305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency.
    Couzinet B; Lestrat N; Brailly S; Forest M; Schaison G
    J Clin Endocrinol Metab; 1988 Mar; 66(3):552-6. PubMed ID: 3127417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism.
    Mannaerts B; Fauser B; Lahlou N; Harlin J; Shoham Z; Bennink HC; Bouchard P
    Fertil Steril; 1996 Feb; 65(2):406-10. PubMed ID: 8566271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating bioactive and immunoreactive recombinant human follicle stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects.
    Matikainen T; De Leeuw R; Mannaerts B; Huhtaniemi I
    Fertil Steril; 1994 Jan; 61(1):62-9. PubMed ID: 8293846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489*) in gonadotropin-deficient volunteers.
    Mannaerts B; Shoham Z; Schoot D; Bouchard P; Harlin J; Fauser B; Jacobs H; Rombout F; Coelingh Bennink H
    Fertil Steril; 1993 Jan; 59(1):108-14. PubMed ID: 8419196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
    Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of recombinant human luteinizing hormone after intravenous, intramuscular, and subcutaneous administration in monkeys and comparison with intravenous administration of pituitary human luteinizing hormone.
    Porchet HC; Le Cotonnec JY; Neuteboom B; Canali S; Zanolo G
    J Clin Endocrinol Metab; 1995 Feb; 80(2):667-73. PubMed ID: 7852534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absorption and uptake of recombinant human follicle-stimulating hormone through vaginal subcutaneous injections--a pharmacokinetic study.
    Hsu CC; Kuo HC; Hsu CT; Gu Q
    Reprod Biol Endocrinol; 2009 Oct; 7():107. PubMed ID: 19807931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant vs. urinary follicle-stimulating hormone in couples undergoing intrauterine insemination. A randomized study.
    Isaza V; Requena A; García-Velasco JA; Remohí J; Pellicer A; Simón C
    J Reprod Med; 2003 Feb; 48(2):112-8. PubMed ID: 12621795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The population pharmacokinetics of recombinant- and urinary-human follicle stimulating hormone in women.
    Karlsson MO; Wade JR; Loumaye E; Munafo A
    Br J Clin Pharmacol; 1998 Jan; 45(1):13-20. PubMed ID: 9489588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH.
    le Cotonnec JY; Porchet HC; Beltrami V; Khan A; Toon S; Rowland M
    Fertil Steril; 1994 Apr; 61(4):669-78. PubMed ID: 8150109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.